Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Pharmacia describes new protein kinase inhibitors, their preparation and use

March 22, 2004

GTx enters collaboration and license agreement with Ortho Biotech for andarine

March 22, 2004

Greater prevention of breast cancer recurrence with exemestane

March 22, 2004

Recombinant immunotoxins against breast cancer, osteosarcoma and neuroblastoma

March 22, 2004

Corgenix Medical and Genesis Bioventures sign merger agreement

March 19, 2004

Maxim reacquires rights to MX-2105 series

March 19, 2004

Novel antiangiogenic tyrosine kinase inhibitor claimed by Boehringer Ingelheim

March 19, 2004

Launch of new Salagen dosage

March 19, 2004

Crucell and NeoTropiX enter PER.C6 technology licensing agreement

March 18, 2004

AstraZeneca team prepares and tests new Tie-2 inhibitors

March 18, 2004

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 23, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 23, 2026.
Neurotrimin unveiled as marker in intellectual disability
BioWorld Science
Neurotrimin (NTM) is a member of the IgLON family, the disruption of which has been tied to emotional learning deficits and anxiety-like behavior in animal...
Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease
BioWorld Science
Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...